DMK Pharmaceuticals
DMK Pharmaceuticals, formerly Adamis Pharma, is a clinical stage neuro-biotechnology company developing products to address areas of significant unmet medical need.

Year Established: 2006
Stock Ticker: DMK
Exchange: NASDAQ